BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial

Reuters
Dec 02
BRIEF-Painreform Commences Development For Ocuring™-<a href="https://laohu8.com/S/TKKD.SI">K</a> Phase II Trial

Dec 2 (Reuters) - PainReform Ltd PRFX.O:

  • PAINREFORM COMMENCES DEVELOPMENT FOR OCURING™-K PHASE II TRIAL, LAYERBIO’S DROP-LESS SUSTAINED-RELEASE OCULAR THERAPY

Source text: ID:nGNX2yr8dv

Further company coverage: PRFX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10